Back to Research Studies
    Ankle/Achilles
    Level 4 Evidence
    Achilles Tendinopathy
    Significant Benefit

    Platelet-Rich Plasma Treatment in Chronic Achilles Tendinosis

    Monto RR · Foot & Ankle International (2012)

    DOI: 10.3113/FAI.2012.0379

    This prospective case series treated 30 patients with chronic non-insertional Achilles tendinosis with a single PRP injection under ultrasound guidance. AOFAS scores improved dramatically from 55 to 96 at 24 months. Despite the striking improvement, the study lacked a control group, limiting causal inference. It stands as one of the most optimistic reports for PRP in Achilles tendinopathy but must be interpreted alongside the negative de Vos 2010 RCT.

    Clinical Relevance

    Illustrates the challenge of interpreting PRP evidence: uncontrolled case series show dramatic results, but controlled trials often do not. The gap likely reflects natural history, placebo effect, and the specific contribution of eccentric exercise programs.

    Key Takeaways

    • AOFAS improved from 55 to 96 at 24 months (dramatic improvement)
    • No control group (case series design)
    • All patients had chronic disease refractory to conservative treatment
    • Results contrast sharply with de Vos 2010 negative RCT
    • Ultrasound-guided injection may have contributed to favorable results

    Key Findings

    Significant improvement in AOFAS scores from 55 to 96 at final follow-up. Results maintained at 24 months with no adverse effects.

    Clinical Context

    Study Design

    Prospective Case Series

    Condition

    Chronic Non-insertional Achilles Tendinosis

    Sample Size

    30 patients

    Follow-up

    24 months

    Control Group

    None (single-arm study)

    Primary Outcome

    AOFAS Score

    PRP Protocol & Intervention

    Injection Frequency

    1 injection(s)

    Guidance Method

    Ultrasound